Moderna to charge US$25 to US$37 for COVID-19 vaccine

Moderna to charge US$25 to US$37 for COVID-19 vaccine

FILE PHOTO: MODERNA ANNOUNCES A VACCINE AGAINST COVID-19 EFFECTIVE AT 94.5%
FILE PHOTO: Coronavirus: On November 16, 2020, US biotech company Moderna announced a vaccine against COVID-19 that is 94.5% effective. Montreal, November 16, 2020./File Photo

FRANKFURT: Moderna will charge governments between US$25 and US$37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

"Our vaccine therefore costs about the same as a flu shot, which is between US$10 and US$50," he was quoted as saying.

On Monday (Nov 16), an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below US$25 per dose.

"Nothing is signed yet, but we're close to a deal with the EU Commission. We want to deliver to Europe and are in constructive talks," Bancel told WamS, adding it was just a "matter of days" until a contract would be ready.

Moderna has said its experimental vaccine is 94.5 per cent effective in preventing COVID-19, based on interim data from a late-stage clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.

The EU has been in talks with Moderna for its experimental COVID-19 vaccine at least since July.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters/nh

Bookmark